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MRI of the Breast for the Detection and
Assessment of the Size of Ductal
Carcinoma in Situ
Objective: The aim of the study was to compare the accuracy of magnetic res-
onance imaging (MRI) and mammography for the detection and assessment of
the size of ductal carcinoma in situ (DCIS).
Materials and Methods: The preoperative contrast-enhanced MRI and mam-
mography were analyzed in respect of the detection and assessment of the size
of DCIS in 72 patients (age range: 30 67 years, mean age: 47 years). The MRI
and mammographic measurements were compared with the histopathologic size
with using the Pearson’s correlation coefficients and the Mann-Whitney u test.
We evaluated whether the breast density, the tumor nuclear grade, the presence
of comedo necrosis and microinvasion influenced the MRI and mammographic
size estimates by using the chi-square test.
Results: Of the 72 DCIS lesions, 68 (94%) were detected by MRI and 62
(86%) were detected by mammography. Overall, the Pearson’s correlation of the
size between MRI and histopathology was 0.786 versus 0.633 between mam-
mography and histopathology (p < 0.001). MRI underestimated the size by more
than 1 cm (including false negative examination) in 12 patients (17%), was accu-
rate in 52 patients (72%) and overestimated the size by more than 1 cm in eight
patients (11%) whereas mammography underestimated the size in 25 patients
(35%), was accurate in 31 patients (43%) and overestimated the size in 16
patients (22%). The MRI, but not the mammography, showed significant correla-
tion for the assessment of the size of  tumor in noncomedo DCIS (p < 0.001 vs p
= 0.060). The assessment of tumor size by MRI was affected by the nuclear
grade (p = 0.008) and the presence of comedo necrosis (p = 0.029), but not by
the breast density (p = 0.747) or microinvasion (p = 0.093). 
Conclusion: MRI was more accurate for the detection and assessment of the
size of DCIS than mammography.
uctal carcinoma in situ (DCIS) accounts for 15 20% of all detected
breast cancers and for 25 56% of the clinically occult cancers detected
by mammography (1). On mammography, from 62 to 98% of DCIS
lesions are detected by the presence of calcifications, with from 2 to 23% of them
manifesting only as a mass or an asymmetric density. DCIS is  a multiform disease
with different growth patterns and heterogeneous set of clinical signs and symptoms
(1 3). 
Conservative surgery of breast cancer has recently become an increasingly common
treatment for DCIS (4). Accurate information about the tumor size and its distribution
is important in preoperative treatment planning. Mammography, however, has
relative limitations for detecting DCIS and assessing the tumor size because noncalci-
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Dfied DCIS foci are not depictable in the dense breasts, and
calcifications associated with benign histology are
sometimes difficult to differentiate from malignant
calcifications. Recent studies have shown that magnetic
resonance imaging (MRI) is more accurate than mammog-
raphy for detecting and assessing the tumor size in patients
with invasive cancer (5 10). However, the diagnostic
value of MRI for detecting and predicting the tumor size of
DCIS is still controversial (11 14). 
The purpose of this study was to compare the accuracy
of MRI and mammography for the detection and assess-
ment of the size of DCIS.
MATERIALS AND METHODS
Patients
Between October 2003 and September 2005, 260
patients were diagnosed with DCIS at our department. Of
these patients, 100 patients had breast MRI performed
before surgery. Cases (n = 19) that underwent excisional
biopsy before MRI and multifocal or multicentric lesions (n
= 9) were excluded from the study, because of the
difficulty in estimating the exact tumor size. Thus, 72
patients (age range: 30 67 years, mean age: 47 years)
were included in this study. Of these 72 patients, 43 (60%)
presented with a screening mammographic abnormality,
22 (31%) with a palpable mass, six (8%) with breast pain
and one (1%) with bloody nipple discharge. Forty patients
underwent breast conservative operations, and 32 patients
underwent mastectomy. This study was conducted with the
approval of our institutional review board; informed
consent was not required.
Imaging 
Mammography was performed with a full-field digital
mammography system (Senographe 2000D, GE Medical
Systems, Milwaukee, WI). Routine mediolateral oblique
and craniocaudal mammograms were obtained in all the
patients, and additional spot-compression with magnifica-
tion and true lateral images were available in all but one
patient. Of the 72 patients, five (7%) had almost entirely
fatty breasts (BI-RADS grade 1, < 25% glandular), ten
(14%) had scattered fibroglandular tissue in fatty breasts
(grade 2, approximately 25 50% glandular), 33 (46%)
had heterogeneously dense breasts (grade 3, approxi-
mately 51 75% glandular) and 24 (33%) had extremely
dense breasts (grade 4, > 75% glandular). On the
mammography, the index lesion was seen as microcalci-
fications alone in 31 (43%) patients and as a mass with (n
= 4) or without (n = 27) microcalcifications in 31 (44%)
patients. No mammographic abnormalities were found in
ten (14%) patients.
MRI was performed with the patient in a prone position
and with using a dedicated phase-array breast coil. Of the
72 patients, a 1.5-T system (Magnetom Sonata, Siemens
Medical Solutions, Erlangen, Germany) was used in 66
patients. Unenhanced fat-suppressed T2- weighted turbo
spin echo sagittal images were obtained. The image
parameters were TR/TE = 9120/82, flip angle: 180 degree
and field of view (FOV): 170 170 mm. The slice thickness
was 1.0 mm. Gadolinium-DTPA (Magnevist [0.1
mmol/kg], Schering, Berlin, Germany) was administrated
manually as an intravenous injection. T1 three-dimensional
fast low angle shot (3D FLASH) dynamic sequences were
performed with one pre-enhanced and four post-enhanced
series in the unilateral sagittal images. The image parame-
ters were TR/TE = 4.9/1.8, flip angle: 0 degree and FOV:
170 170 mm. The acquisition time was 84 seconds, and
the slice thickness was 1 1.6 mm without a gap. The
interval between the start of the image acquisition and the
contrast material injection was 15 seconds. The post
processing included early subtraction (i.e., first post-
contrast images minus pre-contrast images) and reverse
subtraction (i.e., first post-contrast images minus fourth
post-contrast images) for the dynamic studies, the calcula-
tion of the time-intensity curves of the enhancing regions
and the maximum intensity projection. After the dynamic
studies, delayed T1 weighted spin echo images were
acquired in the axial planes (TR/TE: 718/11, flip angle: 90
degrees, 2 mm thickness, 3.2 mm gap, FOV: 300 300
mm). The approximate total time was 30 minutes per one
examination. A 1.5 T imager (Signa; GE Medical Systems,
Milwaukee, WI) was used in six patients. Unenhanced fat-
suppressed T2- weighted turbo spin echo sagittal images
were obtained. The image parameters were TR/TE =
5000/105, flip angle: 90 degrees and FOV: 170 170 mm.
The slice thickness was 1.0 5.0 mm. Gadolinium-DTPA
(Magnevist [0.1 mmol/kg], Schering, Berlin, Germany) was
administrated manually as an intravenous injection. A T1-
three dimensional spoiled gradient-echo (SPGR) sequence
in the unilateral sagittal images was performed, with one
pre-contrast and two post-contrast series. The image
parameters were TR/TE = 19.7/1.8, flip angle: 0 degree
and FOV: 170 170 mm. The acquisition time was 240
seconds and the slice thickness was 1.0 2.5 mm without a
gap. MRI and mammography were performed on the same
day.
Biopsy, Surgery and Histopathology
The diagnosis of DCIS was obtained before the preoper-
ative MRI and mammography by fine needle aspiration in
13 patients and 14-guage (n = 18) or 11-guage (n = 34)
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during the operation in the remaining seven patients. All
the patients underwent surgery within one week of the
preoperative MRI and mammography. In our institution,
most patients with a tumor larger than 5 cm and the
patients with multicentric cancer undergo mastectomy
instead of a breast conservative operation. The patient’s
preference and the size of the breast were considered in all
the cases. 
After lumpectomy or mastectomy, a gross specimen was
evaluated with serial 10 mm slices by the pathologists, and
additional slices were prepared from any gross suspicious
areas. The maximum lesion size by histopathology was
used as a reference standard. DCIS was classified according
to the nuclear grade (high and non-high), the presence of
comedo necrosis (comedo and noncomedo type) and
microinvasion (microinvasive and pure). Non-high nuclear
grade included the low and intermediate grade DCIS. We
defined microinvasion as an extension of the cancer cells
beyond the basement membrane into the adjacent tissue
with no focus, more than 0.1 cm in diameter. 
Image Evaluation
All lesions detected by MRI and mammography were
retrospectively analyzed and assessed in consensus by two
radiologists. At the time of the retrospective review, the
radiologists were not aware of the histopathologic results,
clinical information or the other radiologic images.
Microcalcifications of pleomorphic shape, linear, ductal or
segmental distribution, irregular mass or asymmetry were
defined as positive mammography results (1). A positive
MRI was defined if the signal intensity was higher than that
of the breast parenchyma on the early subtraction images,
and the morphology presented as clumped or heteroge-
neous ductal enhancement or a focal area of enhancement
with irregular borders (5, 6, 15). We considered a mass as
benign if it was well-circumscribed and homogeneous
enhancement on the early subtraction images or high signal
intensity on T2-weighted images. The best image depicting
the abnormality was selected from the early subtraction
images. The tumor size was measured by assessing the
longest axis of the lesion with using electronic calipers.
When no lesion was present on the MRI or mammography,
the size was set to 0 cm. 
After analyzing the MRI and mammography, the
pathologic and surgical records were reviewed by one of
the two radiologists. The accuracy of the assessment of the
tumor size by MRI and mammography was evaluated, and
the cases were classified as accurate, underestimation or
overestimation. Accurate estimation was defined when the
difference between the imaging and histopathologic size of
the lesion was less than 1 cm, underestimation was defined
as no visualization or cases that were underestimated by
more than 1 cm with an imaging modality, and overestima-
tion was defined as cases overestimated by more than 1 cm
with an imaging modality as compared with the
histopathologic size. If there was a change in the operative
methods after MRI, then it was recorded.
Statistical Evaluation
Pearson’s correlation coefficients were calculated to
determine the association between the MRI and
mammographic measurements and the histopathologic
size. Correlation coefficients were calculated between the
MRI or mammographic measurement and the histopatho-
logic size, according to the breast density, the
mammographic findings (either microcalcifications alone or
a mass with or without microcalcifications), the nuclear
grade, the presence of comedo necrosis and microinvasion.
Graphs were used to present the relationship between the
MRI and mammographic measurements and the
histopathologic size. The Mann-Whitney u test was used to
evaluate the statistical significance of the differences in size
between MRI or mammography and the histopathology.
We also evaluated whether the breast density, the
mammographic findings, the tumor nuclear grade and the
presence of comedo necrosis and microinvasion influenced
the assessment of the size of DCIS by MRI and mammog-
raphy by using the chi-square test. A p value of less than
0.05 was considered statistically significant.
RESULTS
The histopathologic examinations revealed high grade
DCIS in 43 patients and non-high grade DCIS in 29
patients. The comedo type was noted in 40 patients and
the noncomedo type was noted in 32 patients. Pure DCIS
was found in 58 patients and DCIS with microinvasion was
found in 14. Forty lesions were located in the left breast,
and 32 were located in the right. Of the 72 DCIS lesions,
eight were detected only by MRI, 60 by MRI and
mammography and two only by mammography. Two
DCIS lesions (3 cm non-high grade, noncomedo DCIS and
0.7 cm high grade, comedo DCIS) were detected only by
pathology. Thus, 68 (94%) were detected by MRI and 62
(86%) were detected by mammography. All the 10 false
negative lesions detected by mammography were within
the dense pattern of breast parenchyma, but seven of these
lesions were detected by MRI. For the four false negative
lesions detected by MRI, two were detected as microcalci-
fications by mammography. Three of these four false
negative lesions by MRI were the non-high grade,
Kim et al.
34 Korean J Radiol 8(1), February 2007noncomedo type, and one was the high-grade, comedo
type. The mean histopathologic size of the false negative
lesions by mammography was 2.3 cm (0.7 4.5 cm) and
that by MRI was 2.1 cm (0.5 4.0 cm), whereas the mean
tumor size detected by mammography was 3.2 cm (0.4
10.0 cm) and that by MRI was 3.1 cm (0.4 10.0 cm),
which revealed no significant statistical differences.
The overall mean size as predicted by MRI and
mammography was 3.2 cm (0 10.0 cm) and 2.7 cm (0
11.2 cm), respectively, compared with 3.1 cm (0.4 10.0
cm) on the histopathology (Table 1). The overall Pearson’s
correlation coefficient for the size between MRI and
histopathology was 0.786 (p < 0.001) and that for the size
between mammography and histopathology was 0.633 (p
< 0.001). On MRI, the size correlation coefficients of the
high grade, comedo type and the DCIS with microinvasion
were higher than those of the non-high grade, noncomedo
type and pure DCIS (Table 1). MRI, but not mammogra-
phy, showed a significant correlation with the actual tumor
size for noncomedo DCIS (p < 0.001 vs p = 0.060). The
graph depicted a close fit between the MRI and histopatho-
logic sizes (Fig. 1). The size discrepancy and the span were
smaller for the MRI measurements, as compared with the
mammographic differences. The mean absolute difference
in the size for all lesions was 0.8 cm (0 6.5 cm) on MRI
and 1.5 cm (0 7.3 cm) on mammography.
MRI underestimated the size of DCIS in 12 patients
(17%), was accurate in 52 patients (72%) and overesti-
mated the size in eight patients (11%) (Figs. 2 4), whereas
mammography underestimated the size of DCIS in 25
patients (35%), was accurate in 31 patients (43%) and
overestimated the size in 16 patients (22%) (Table 2). MRI
was more accurate than mammography in assessing the
lesion size (p < 0.001, Mann-Whitney u test). Based on
these MRI findings, a change of the operative methods was
found in 13 patients (18%). A change of the planned
mastectomy to necessary breast conservative operation
was in five patients (7%), and that of the planned breast
conservative operation to necessary mastectomy was in six
patients (8%). However, two patients (3%) underwent
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Fig. 1. Graph showing the correlation between the histopathologi-
cally determined DCIS size and the corresponding DCIS size as
measured by MRI and mammography. The mean absolute differ-
ence in the size between imaging and histopathology was 0.8 cm
(0 6.5 cm) by MRI and 1.5 cm (0 7.3 cm) by mammography. 
DCIS = Ductal carinoma in situ, MRI = Magnetic resonance
imaging, MMG = Mammography.
Table 1. Mean Size of DCIS and the Correlation Coefficients by MRI and Mammography According to the Breast Density, 
the Mammographic Findings and the Histopathologic Results 
Breast  Mammographic  Nuclear  Presence of Presence of
Density Findings* Grade Comedo Necrosis Microinvasion Overall
Fatty Dense Calcifications  Mass  High Non-high  Comedo  Noncomedo  Microinvasive  Pure 
(n = 72)
(n = 15) (n = 57) (n = 31) (n = 31) (n = 43) (n = 29) (n = 40) (n = 32) (n = 14) (n = 58)
MRI Size (cm) 3.62 3.04 2.77 3.98 3.53 2.61 3.92 2.21 3.49 3.08 3.16
C 0.708 0.814 0.738 0.804 0.794 0.788 0.816 0.651 0.951 0.751 0.786
p value 0.002 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Mammo- Size 
graphy (cm)
3.79 2.42 3.81 3.81 3.22 1.93 3.72 1.44 3.03 2.63 2.71
C 0.650 0.642 0.774 0.703 0.637 0.644 0.687 0.331 0.712 0.619 0.633
p value 0.006 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.060 < 0.001 < 0.001 < 0.001
Histopa- Size 
thology (cm)
3.21 2.79 2.82 3.57 3.15 2.55 3.43 2.21 3.51 2.90 3.07
Note. DCIS = ductal carcinoma in situ, C = Pearson’s correlation coefficients
* No mammographic abnormalities were noted in ten (14%) patients.unnecessary mastectomy instead of the planned breast
conservative operation. 
Of the 72 patients who were included into the study,
accurate assessment of the size of the lesion by mammog-
raphy was found in 47% (seven of 15) with fatty breasts
(BI-RADS grade 1 or 2 breast density) and 42% (24 of 57)
with dense breasts (BI-RADS grade 3 or 4 breast density)
(p = 0.751), 65% (20 of 31) with microcalcifications alone
and 35% (11 of 31) with a mass with or without microcal-
cifications (p = 0.004), 49% (21 of 43) with high grade
DCIS and 34% (10 of 29) with non-high grade DCIS (p =
0.228), 45% (18 of 40) with comedo DCIS and 41% (13 of
32) with noncomedo DCIS (p = 0.709), 57% (8 of 14) with
microinvasive DCIS and 40% (23 of 58) with pure DCIS
(p = 0.236), whereas accurate assessment of the size by
MRI was found in 67% (ten of 15) with fatty breasts and
Kim et al.
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Fig. 2. A 45-year-old woman with a 5 cm high grade, comedo type DCIS, which was more accurately assessed by MRI than by
mammography. 
A. Spot-magnification mediolateral oblique mammogram shows a 1.1 cm cluster of the pleomorphic microcalcifications (arrow) in the left
breast. The metallic marker is on the palpable area.
B. Dynamic contrast-enhanced sagittal subtraction MR image shows a 5 cm sized, segmentally distributed, heterogeneous enhancing
lesion (arrows) in the left breast.
AB
Fig. 3. A 43-year-old woman with a 2 cm high grade, comedo type DCIS, which was more accurately assessed by mammography than
by MRI. 
A. Spot-magnification mediolateral oblique mammogram shows a 1.4 cm segmental distribution of the pleomorphic microcalcifications
(arrow) in the right breast. 
B. Dynamic contrast-enhanced sagittal subtraction MR image shows a 0.5 cm sized, irregular enhancing lesion (arrow) in the right breast.
AB74% (42 of 57) with dense breasts (p = 0.747), 77% (24 of
31) with microcalcifications alone and 77% (24 of 31) with
a mass with or without microcalcifications (p = 0.999),
84% (36 of 43) with high grade DCIS and 55% (16 of 29)
with non-high grade DCIS (p = 0.008), 83% (33 of 40)
with comedo DCIS and 59% (19 of 32) with noncomedo
DCIS (p = 0.029), 93% (13 of 14) with microinvasive
DCIS and 67% (39 of 58) with pure DCIS (p = 0.093)
(Table 2). 
DISCUSSION
The presence of dense tissue on mammography often
obscures the tumor, and this makes detection and size
MR Imaging Detection and Assessment of Ductal Carcinoma in Situ
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Fig. 4. A 33-year-old woman with a 2.7 cm high grade, comedo type DCIS, which was accurately assessed by both MRI and mammog-
raphy. 
A. Spot-magnification mediolateral oblique mammogram shows a 2.7 cm segmental distribution of the pleomorphic microcalcifications
(arrow) in the left breast. 
B, C. Dynamic contrast-enhanced sagittal subtraction MR images shows a 2.7 cm sized, clumped ductal enhancement (arrows) in the
left breast.
ABC
Table 2. Assessment of the Size of DCIS by MRI and Mammography According to the Breast Density, the Mammographic
Findings and the Histopathologic Result
Breast Mammographic Nuclear  Comedo 
Microinvasion
Density Findings Grade Necrosis Overall
Fatty Dense Calcifications Mass High Non-high Comedo Noncomedo Microinvasive Pure
(n = 72)
(n = 15) (n = 57) (n = 31) (n = 31) (n = 43) (n = 29) (n = 40) (n = 32) (n = 14) (n = 58)
MRI Accurate* (%) 10 (67) 42 (74) 24 (77) 24 (77) 36 (84) 16 (55) 33 (83) 19 (59) 13 (93) 39 (67) 52 (72)
Underesti-
mation   (%)
3 (20) 9 (16) 4 (13) 4 ( 13) 3 (7) 9 (31) 3 (8) 9 (28) 1 (7) 11 (19) 12 (17)
Overesti-
mation   (%)
2 (13) 6 (11) 3 (10) 3 (10) 4 (9) 4 (14) 4 (10) 4 (13) 0 (0) 8 (14) 8 (11)
Mammo- Accurate* 
graphy (%)
7 (47) 24 (42) 20 (65) 11 (35) 21 (49) 10 (34) 18 (45) 13 (41) 8 (57) 23 (40) 31 (43)
Underesti-
mation   (%)
3 (20) 22 (39) 6 (19) 9 (29) 11 (26) 14 (48) 9 (23) 16 (50) 4 (29) 21 (36) 25 (35)
Overesti-
mation   (%)
5 (33) 11 (19) 5 (16) 11 (35) 11 (26) 5 (17) 13 (33) 3 (9) 2 (14) 14 (24) 16 (22)
Note. DCIS = ductal carcinoma in situ
* Accurate estimation was defined as less than 1 cm for the difference between the imaging and histopathologic sizes.
Underestimation was defined as no visualization or cases underestimated by more than 1 cm with an imaging modality as compared with the
histopathologic size.
Overestimation was defined as cases overestimated by more than 1 cm with an imaging modality as compared with the histopathologic size.
No mammographic abnormalities were noted in ten (14%) patients.assessment difficult (11). In our study, all the 10 false
negative lesions detected by mammography were in
patients with dense breasts. However, the detection of
DCIS and the assessment of the size by MRI were not
significantly affected by the breast density. The assessment
of the tumor size by MRI was accurate (within 1 cm as
compared with the histopathologic size) in 72% (52 of 72),
whereas the mammographic assessment was accurate in
43% (31 of 72). As compared with mammography, MRI
showed significant correlation in the assessment of the
tumor size in both the noncomedo (p < 0.001 vs p = 0.06)
and comedo DCIS (p < 0.001 vs p < 0.001). Thus, our
results suggest that MRI has the potential to provide more
information for preoperative planning particularly in
patients with dense breasts and with noncomedo DCIS, as
compared with mammography.
The previously reported sensitivities for detecting DCIS
lesions by MRI have varied; they have ranged from 40% to
100%, which can possibly be explained by the variable
levels of angiogenesis in these lesions or the different MRI
techniques (5, 6, 12 16). Even if we exclude DCIS with
microinvasion, the sensitivity of detecting DCIS lesions by
MRI was 93% (54 of 58), and this was better than a recent
multicenter trial with the sensitivity of 73% (46 of 63) (17).
Several studies have reported that the variable detected
rate by MRI may be related to the tumor size (13, 17, 18).
In our study, the histopathologic size of the false negative
cases by MRI ranged from 0.5 cm to 4.0 cm (mean, 2.1 cm),
whereas the size of the detected cases by MRI ranged from
0.4 cm to 10.0 cm (mean, 3.1 cm), and this difference was
not statistically significant. Thus the size of the lesions alone
was an incomplete explanation for the variable reported
detection sensitivities of DCIS by MRI. Of the four DCIS
lesions not detected by MRI in our study, three were the
non-high grade and noncomedo type. Assessment of the
tumor size by MRI was affected by the nuclear grade (p =
0.008) and the presence of comedo necrosis (p = 0.029);
accurate estimation of the tumor size was found in 84% (36
of 43 patients) of the high grade DCIS and 83% (33 of 40
patients) of the comedo DCIS, whereas accurate estimation
of the tumor size was found in only 55% (16 of 29 patients)
of the non-high grade DCIS and 59% (19 of 32 patients) of
the noncomedo DCIS. High grade or comedo DCIS tends to
be more aggressive, which may explain the early contrast
enhancement and the high sensitivity by MRI (19, 20). Our
study suggests that histopathologic characteristics of tumor
affect the sensitivity of detection of DCIS and the assess-
ment of the tumor size by MRI. 
Our study had limitations. First, this study was a
retrospective design. Second, multicentric or multifocal
cancer was excluded Third, although this study included 72
patients, some of the subgroups contained only few
patients, which limited the reliability of the results.
In conclusion, MRI was more accurate for the detection
and assessment of the size of DCIS than mammography.
As compared with mammography, MRI showed significant
correlation for the assessment of the tumor size in
noncomedo DCIS, and the assessment of the tumor size
was affected by the nuclear grade and the presence of
comedo necrosis. 
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